The Chief Financial Officer (CFO) will provide financial leadership and oversight for the HDSA.
The CFO is a key member of the senior leadership team and is responsible for all financial aspects of the organization, including strategic financial planning, accounting, budgeting, forecasting, treasury operations, and risk management. This role requires a professional who can manage and improve financial systems while upholding the highest standards of integrity and transparency.
As we prepare for potential disease-modifying therapies, the CFO will be instrumental in building the financial and operational infrastructure to support significant growth in research funding, patient services, and advocacy efforts and to ensure the appropriate deployment of the organization’s resources.
The new CFO will have the opportunity to lead the development of a long-term investment strategy in collaboration with the Investment Committee with an eye toward sustainable growth for the organization and its assets.
The CFO will also be in charge of helping to modernize the organizational infrastructure, alongside the Director of Operations, to optimize processes and create internal efficiencies.